Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it. Our objective was to assess the efficacy a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-09-01
Col·lecció:	Cancer Medicine
Matèries:	prostate cancer chemotherapy metastasis cancer management urological oncology
Accés en línia:	https://doi.org/10.1002/cam4.4172
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!